Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 2
1985 2
1987 6
1989 1
1990 2
1991 2
1992 2
1993 1
1995 1
1996 1
1997 4
1998 1
1999 3
2001 3
2002 1
2003 2
2004 1
2005 1
2008 1
2010 1
2011 1
2012 2
2013 2
2014 2
2016 1
2017 2
2018 3
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Olfactory neuroblastoma: a single-center experience.
König M, Osnes T, Jebsen P, Evensen JF, Meling TR. König M, et al. Among authors: evensen jf. Neurosurg Rev. 2018 Jan;41(1):323-331. doi: 10.1007/s10143-017-0859-3. Epub 2017 May 25. Neurosurg Rev. 2018. PMID: 28540633
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C. Overgaard J, et al. Among authors: evensen jf. Radiother Oncol. 2018 Apr;127(1):12-19. doi: 10.1016/j.radonc.2018.02.018. Epub 2018 Mar 6. Radiother Oncol. 2018. PMID: 29523409 Clinical Trial.
DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC).
Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J. Evensen JF, et al. Acta Oncol. 2019 Oct;58(10):1502-1505. doi: 10.1080/0284186X.2019.1629012. Epub 2019 Jul 8. Acta Oncol. 2019. PMID: 31282236 Clinical Trial. No abstract available.
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.
Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J; Danish Head and Neck Cancer Group (DAHANCA). Lassen P, et al. Among authors: evensen jf. Radiother Oncol. 2014 Dec;113(3):310-6. doi: 10.1016/j.radonc.2014.11.032. Epub 2014 Nov 26. Radiother Oncol. 2014. PMID: 25544647 Free article.
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.
Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG. Brøndum L, et al. Among authors: evensen jf. Acta Oncol. 2018 Sep;57(9):1159-1164. doi: 10.1080/0284186X.2018.1464664. Epub 2018 May 17. Acta Oncol. 2018. PMID: 29771169 Clinical Trial.
52 results